Alcon acquires Belkin Vision for $335 million

9 May, 2024

We are pleased to announce that our valued client, Alcon Inc. (an American Swiss pharmaceuticals company that is traded on the NYSE) has acquired Belkin Vision, an Israeli glaucoma treatment company, for an approximated $335 million.

Congratulations to Arnon, Tadmor-Levy’s team, led by Partner Ezra Gross, Nataly Margalit, Ofir Levy, Ofir Paz, Eli Greenbaum, Tamar Tavory, Neta Goshen Brami, Miriam Friedmann, Lihi Katzenelson, Shai Bakal as well as Adv. Tali Salzman, Itamar Brown, Elizabeth Krishmarov Chanan, Derora Tropp, Maayan Rublin Malka, Michael Portman and Chen Lanir and intern Nimrod Tal.

Read the full article here >>>

Want to know more?
Contact us

Shiri Menache

Head of Marketing and Business Development

Matan Bar-Nir

Press Officer, OH! PR